SOX2 and neoplasm: Mechanistically, collagen I enhances stemness (Sox2, Oct4, CD133) through Slug-dependent EMT and, via DDR1–CD44 signaling, disrupts Hippo pathway regulation to activate YAP, thereby reinforcing therapeutic resistance and tumor progression [140].